Drug Type Gene therapy |
Synonyms ADR 002, ADR-002, ADR-002K |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ischemic cardiomyopathy | Phase 1 | JP | 01 Nov 2019 |